PMA N50510S131
- Device
- VITEK 2 GRAM POSITIVE AST FOR CEFOTAXIME
- Applicant
- Biomerieux Vitek, Inc.
- PMA number
- N50510
- Supplement
- S131
- Product code
- LTW
- Decision date
- 2000-06-06
- Classification
- Susceptibility Test Cards, Antimicrobial
- Generic name
- Susceptibility test cards, antimicrobial
- Approval order statement
- APPROVAL FOR THE ADDITION OF THE ANTIBIOTIC CEFOTAXIME AT CONCENTRATIONS OF 0.06, 0.25, 0.5 AND 1 MICROGRAMS/ML TO THE VITEK(R) 2 S. PNEUMONIAE SUSCEPTIBILITY TEST SYSTEM. THE DEVICE WILL BE MARKETED UNDER THE TRADE NAME VITEK(R) 2 S. PNEUMONIAE SUSCEPTIBILITY TEST CARDS FOR USE IN THE VITEK 2 SYSTEM AND IS INDICATED FOR USE FOR THE SUSCEPTIBILITY TESTING OF STREPTOCOCCUS PNEUMONIAE TO CEFOTAXIME IN THE RANGE OF <=0.06 TO >=4 MICROGRAMS/ML.
Current openFDA PMA Record#
- Device
- VITEK 2 GRAM POSITIVE AST FOR CEFOTAXIME
- Applicant
- Biomerieux Vitek, Inc.
- PMA number
- N50510
- Supplement
- S131
- Product code
- LTW
- Generic name
- Susceptibility test cards, antimicrobial
- Decision date
- 2000-06-06
- Decision code
- APPR
- Date received
- 2000-04-05
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Change Design/Components/Specifications/Material
- Approval order statement
- APPROVAL FOR THE ADDITION OF THE ANTIBIOTIC CEFOTAXIME AT CONCENTRATIONS OF 0.06, 0.25, 0.5 AND 1 MICROGRAMS/ML TO THE VITEK(R) 2 S. PNEUMONIAE SUSCEPTIBILITY TEST SYSTEM. THE DEVICE WILL BE MARKETED UNDER THE TRADE NAME VITEK(R) 2 S. PNEUMONIAE SUSCEPTIBILITY TEST CARDS FOR USE IN THE VITEK 2 SYSTEM AND IS INDICATED FOR USE FOR THE SUSCEPTIBILITY TESTING OF STREPTOCOCCUS PNEUMONIAE TO CEFOTAXIME IN THE RANGE OF =4 MICROGRAMS/ML.